| Name | Title | Contact Details |
|---|
With our focus on improving patient outcomes with evidence-based healing solutions, we develop, market and distribute biotechnology products to physicians, hospitals, clinics and all post-acute care settings. We are constantly seeking long-term partnerships with a focus on products that produce efficacious outcomes at a lower overall cost. Our products are primarily sold in the North American surgical tissue repair and advanced wound care markets.
Wuhan General Group, Inc. through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company that researches, develops and commercialises a range of CBD-based products under the Dr. AnnaRx™ and Medspresso™ brands.
Discover what nutrients your body craves at the cellular level. Habit delivers the first complete personalized nutrition solution, From Test to Table
Partnering with more than 1,800 physicians at more than 235 outpatient surgery centers across the United States, AmSurg is the nationally recognized leader in the development, management and operation of outpatient surgery centers. AmSurg surgery centers provide high quality, low cost surgical services with superior patient satisfaction. We believe in empowering our physician partners to achieve their professional and personal goals by providing innovative operational, clinical and strategic services.